CEO: Robert Azelby

Sector: Healthcare
Industry:Biotechnology

Exchange: NASDAQ Global Market

Country: USA

Description: Alder BioPharmaceuticals Inc is a biotechnology company. It is engaged in the discovery, development, and commercialization of therapeutic antibodies addresses diseases with limited medical options. The company operates across the U.S and Australia.





2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31,
2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,